Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Gonorrhoea

Gonorrhoea

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Gonorrhoea

4 trials tracked for Gonorrhoea: 1 in phase 3 or 4.

4Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 2 2 Phase 1 1
  1. Phase 4 Efficacy of Combination Therapies for Gonorrhea Treatment Completed
  2. Phase 2 Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea Completed
  3. Phase 2 Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination Completed
  4. Phase 1 A Study to Evaluate the Safety, Tolerability and Plasma PK of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Volunteers Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oral topoisomerase II inhibitors show no significant difference from ceftriaxone for uncomplicated gonorrhoea
Infectious Disease Meta-analysis
Oral topoisomerase II inhibitors show no significant difference from ceftriaxone for uncomplicated gonorrhoea Oral Topoisomerase Inhibitors Show Promise for Treating Gonorrhoea
This meta-analysis evaluates oral type II topoisomerase inhibitors, including gepidacin and zoliflodacin, compared to ceftriaxone-based ther…
New oral medications like gepidacin and zoliflodacin show similar success rates to ceftriaxone for treating uncomplicated gonorrhoea.
Sep 3, 2026
Meta-analysis finds doxycycline prophylaxis reduces STI risk in MSM and transgender women
Infectious Disease Meta-analysis
Meta-analysis finds doxycycline prophylaxis reduces STI risk in MSM and transgender women A Common Pill Could Slash Your Risk of Common STIs
A systematic review and meta-analysis of 14 studies in men who have sex with men and transgender women found doxycycline prophylaxis reduced…
A major review of the latest science confirms that a simple antibiotic, taken strategically, offers powerful new protection against chlamydi…
Apr 12, 2026